Dianon Systems develops prostate specific antigen (PSA) II test
This article was originally published in Clinica
Dianon Systems (US) and researchers at the John Hopkins University Medical Center, Maryland, have developed a second- generation prostate specific antigen (PSA) test called PSA II. Presented at the American Urological Association in Orlando, the test may be useful in discriminating between prostate cancer and benign prostatic hyperplasia (BPH), up to seven years before current tests can detect prostate cancer.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.